CJC-1295 NO DAC 5MG: Research Peptide Information and Product Specifications

CJC-1295 NO DAC 5MG is a synthetic research peptide that has attracted scientific interest because of its relationship with growth hormone-releasing hormone (GHRH) signaling. Commonly associated with Modified GRF (1-29), this peptide is investigated in scientific research examining peptide-receptor interactions, endocrine signaling, and growth hormone regulation.

Presented in a 5 mg format, CJC-1295 NO DAC provides a clearly identified product quantity for research documentation and laboratory inventory purposes. Understanding its molecular characteristics, scientific background, and differences from other CJC-1295 formulations is important when evaluating this research peptide.

What Is CJC-1295 NO DAC?

CJC-1295 NO DAC is a synthetic peptide analogue related to growth hormone-releasing hormone. The NO DAC designation means the compound does not contain the Drug Affinity Complex modification associated with the longer-acting CJC-1295 DAC formulation.

It is commonly identified as Modified GRF (1-29), a modified version of the first 29 amino acids of GHRH.

Its molecular structure makes it a subject of scientific interest in research involving GHRH receptor activity and endocrine signaling pathways.

Understanding the NO DAC Formulation

One important characteristic of CJC-1295 NO DAC is the absence of the Drug Affinity Complex modification.

CJC-1295 with DAC and CJC-1295 NO DAC are different peptide formulations. The DAC modification is designed to increase the compound’s association with circulating proteins, influencing its pharmacokinetic characteristics.

The NO DAC version does not have this modification and has different stability and duration characteristics.

Understanding this distinction is essential when comparing research peptide products, reviewing scientific literature, and verifying product specifications.

CJC-1295 NO DAC 5MG Product Specifications

The CJC-1295 NO DAC 5MG designation identifies the compound and its labeled quantity.

Important product specifications include:

• Product name: CJC-1295 NO DAC.
• Common alternative name: Modified GRF (1-29).
• Product quantity: 5 mg as labeled.
• Compound classification: Synthetic research peptide.
• Research focus: GHRH receptor signaling.
• Formulation: Non-DAC peptide analogue.

Researchers should verify the complete chemical identity, molecular sequence, and labeled quantity through manufacturer documentation.

Scientific Research and Growth Hormone Signaling

Growth hormone-releasing hormone is involved in the regulation of growth hormone secretion through interactions with receptors in the pituitary gland.

CJC-1295 NO DAC is studied because of its relationship with this signaling pathway. Scientific investigations involving GHRH analogues help researchers understand peptide structure, receptor interactions, and endocrine regulation.

These research areas contribute to a broader understanding of hormonal signaling and peptide-related biological processes.

However, scientific interest and preliminary findings should not be interpreted as proof of clinical effectiveness or safety.

Why Choose Clearly Documented Research Peptides?

Accurate documentation is essential when evaluating laboratory research materials.

For CJC-1295 NO DAC 5MG, researchers should review the available information before accepting the product into laboratory inventory.

Important quality considerations include:

• Verified chemical identity and molecular sequence.
• Batch or lot identification.
• Purity and analytical testing results.
• Manufacturer information.
• Certificate of Analysis (COA).
• Product-specific storage instructions.

A COA can provide useful batch-specific information and support product traceability.

Storage and Handling Considerations

Peptide stability can vary depending on molecular structure, formulation, and environmental exposure.

CJC-1295 NO DAC 5MG should be stored and handled according to manufacturer-provided instructions.

General laboratory considerations include maintaining appropriate environmental conditions, protecting the original packaging, preserving product identification, and following applicable laboratory safety procedures.

Always consult product-specific documentation rather than assuming that all peptide products have identical storage requirements.

Important Research Disclaimer

CJC-1295 NO DAC 5MG is presented as a research-labeled product for laboratory and scientific investigation. It is not an approved medication or dietary supplement. Its relationship with GHRH signaling does not establish safety or effectiveness for human use, anti-aging, bodybuilding, or treatment of medical conditions.

This description is informational and does not recommend human or veterinary consumption or self-administration. Research materials should be evaluated according to applicable regulations and laboratory safety standards.

Conclusion

CJC-1295 NO DAC 5MG is a synthetic research peptide commonly associated with Modified GRF (1-29) and the scientific study of GHRH signaling pathways.

Its non-DAC formulation distinguishes it from CJC-1295 DAC products, making accurate product identification particularly important. When evaluating this peptide, prioritize verified chemical specifications, batch traceability, analytical documentation, and responsible laboratory practices.